Drugs / Lessertia Fructescens
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00376415 | Sep 2004 → Jan 2005 | — | University of Missouri-Columbia | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lessertia Fructescens | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00376415 ↗ |
| Known as | Sutherlandia frutescens | “Lessertia frutescens (L.) Goldblatt \& J.C. Manning (syn. Sutherlandia frutescens (L.) R. Br.)” NCT00376415 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “indigenous medicines” NCT00376415 ↗ |
| Route | Oral | “received 400mg lessertia fructescens leaf powder capsules twice daily for 3 months” NCT00376415 ↗ |